Polymorphism M55V in gene encoding small ubiquitin-like modifier 4 (SUMO4) protein associates with susceptibility to type 1 (and type 2) diabetes

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 8, 2012, Pages 679-687

  Tang, Song Tao ^a   Peng, Wen Jia ^a   Wang, Chang Jiang ^a   Tang, Hai Qin ^a   Zhang, Qiu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Meta analysis; Polymorphism; SUMO4

Indexed keywords

SUMO 4 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CAUCASIAN; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SUMO 4 GENE; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 84868628796     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2335     Document Type: Article

References (42)

1. Dahlquist G, Blom L, Tuvemo T, et al. The Swedish childhood diabetes study-results from a nine year case register and a one year case-referent study indicating that type 1 insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 1989; 32: 2-6.
2. Li H, Lindholm E, Almgren P, et al. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes. J Clin Endocrinol Metab 2001; 86: 574-582.
3. Guo D, Li M, Zhang Y, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004; 36: 837-841.
4. Wang CY, She JX. SUMO4 and its role in type 1 diabetes pathogenesis. Diabetes Metab Res Rev 2008; 24: 93-102.
5. Noso S, Ikegami H, Fujisawa T, et al. Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populations. Ann N Y Acad Sci 2006; 1079: 41-46.
6. Noso S, Fujisawa T, Kawabata Y, et al. Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese population. J Clin Endocrinol Metab 2007; 92: 2358-2362.
7. Lin HY, Li SL, Yu ML, et al. Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of Type 2 diabetes mellitus in Taiwan. J Endocrinol Invest 2010; 33: 401-405.
8. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293: 1673-1677.
9. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-102.
10. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
13. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
14. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
15. Sedimbi SK, Luo XR, Sanjeevi CB, et al. SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients. Genes Immun 2007; 8: 518-521.
16. Tsurumaru M, Kawasaki E, Ida H, et al. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. J Clin Endocrinol Metab 2006; 91: 3138-3143.
17. Park Y, Park S, Kang J, et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005; 37: 112 author reply 112-113.
18. Noso S, Ikegami H, Fujisawa T, et al. Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes. Diabetes 2005; 54: 3582-3586.
19. Sang Y, Zong W, Liu M, et al. Association of SUMO4 M55V polymorphism with type 1 diabetes in Chinese children. J Pediatr Endocrinol Metab 2010; 23: 1083-1086.
20. Sedimbi SK, Shastry A, Park Y, et al. Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients. Ann N Y Acad Sci 2006; 1079: 273-277.
21. Sedimbi SK, Kanungo A, Shastry A, et al. No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients. Int J Immunogenet 2007; 34: 137-142.
22. Smyth DJ, Howson JM, Lowe CE, et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005; 37: 110-111 author reply 112-113.
23. Wang CY, Yang P, She JX. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005; 37: 112 author reply 112-113.
24. Shimada T, Furukawa Y, Furuta H, et al. SUMO4 Met55Val polymorphism is associated with coronary heart disease in Japanese type 2 diabetes individuals. Diabetes Res Clin Pract 2009; 85: 85-89.
25. Fallah S, Jafarzadeh M, Hedayati M. No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects. Diabetes Res Clin Pract 2010; 90: 191-195.
26. Li B, Li HF, Wang YM, et al. Correlation between 163 A/G polymorphism of SUMO4 gene and diabetic retinopathy. Journal of Kunming Medical University 2010; 4-6.
27. Ji ZZ, Dai J, Xu YC. Association between small ubiquitin-like modifier 4 M55V polymorphism with type 2 diabetes and related factors. Chin J Diabetes Mellitus 2010; 2: 344-348.
28. Gill G. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev 2003; 13: 108-113.
29. Su HL, Li SS. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. Gene 2002; 296: 65-73.
30. Li M, Guo D, Isales CM, et al. SUMO wrestling with type 1 diabetes. J Mol Med (Berl) 2005; 83: 504-513.
31. Mora A, Youn J, Keegan A, et al. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J Immunol 2001; 166: 2218-2227.
32. Yoshimura S, Bondeson J, Brennan FM, et al. Antigen presentation by murine dendritic cells is nuclear factor-kappa B dependent both in vitro and in vivo. Scand J Immunol 2003; 58: 165-172.
33. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998; 2: 233-239.
34. Morton NM, de Groot RP, Cawthorne MA, et al. Interleukin-1beta activates a short STAT-3 isoform in clonal insulin-secreting cells. FEBS Lett 1999; 442: 57-60.
35. Rasschaert J, Ladriere L, Urbain M, et al. Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+interferon-gamma-induced apoptosis in primary pancreatic beta-cells. J Biol Chem 2005; 280: 33984-33991.
36. Darville MI, Eizirik DL. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 1998; 41: 1101-1108.
37. Cnop M, Welsh N, Jonas JC, et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005; 54(Suppl 2): S97-107.
38. Chen G, Hohmeier HE, Newgard CB. Expression of the transcription factor STAT-1 alpha in insulinoma cells protects against cytotoxic effects of multiple cytokines. J Biol Chem 2001; 276: 766-772.
39. Flodstrom-Tullberg M, Yadav D, Hagerkvist R, et al. Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes 2003; 52: 2696-2700.
40. Eizirik DL, Mandrup-Poulsen T. A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001; 44: 2115-2133.
41. Lgssiar A, Hassan M, Schott-Ohly P, et al. Interleukin-11 inhibits NF-kappaB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice. Exp Biol Med (Maywood) 2004; 229: 425-436.
42. Guo D, Han J, Adam BL, et al. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem Biophys Res Commun 2005; 337: 1308-1318.